Smith, Lillian, Juan Mosley, Jarah Yates, and Luke Caswell. “The New Face of Hyperlipidemia Management: Proprotein Convertase Subtilisin Kexin Inhibitors (PCSK-9) and Their Emergent Role As An Alternative To Statin Therapy”. Journal of Pharmacy & Pharmaceutical Sciences 19, no. 1 (March 8, 2016): 137–146. Accessed February 25, 2025. https://journals.library.ualberta.ca/jpps/index.php/JPPS/article/view/25981.